20-19975749-AC-ACC
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_018993.4(RIN2):c.1731dupC(p.Ile578fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,610,188 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0000067 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )
Consequence
RIN2
NM_018993.4 frameshift
NM_018993.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0610
Genes affected
RIN2 (HGNC:18750): (Ras and Rab interactor 2) The RAB5 protein is a small GTPase involved in membrane trafficking in the early endocytic pathway. The protein encoded by this gene binds the GTP-bound form of the RAB5 protein preferentially over the GDP-bound form, and functions as a guanine nucleotide exchange factor for RAB5. The encoded protein is found primarily as a tetramer in the cytoplasm and does not bind other members of the RAB family. Mutations in this gene cause macrocephaly alopecia cutis laxa and scoliosis (MACS) syndrome, an elastic tissue disorder, as well as the related connective tissue disorder, RIN2 syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-19975749-A-AC is Pathogenic according to our data. Variant chr20-19975749-A-AC is described in ClinVar as [Pathogenic]. Clinvar id is 137627.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIN2 | NM_018993.4 | c.1731dupC | p.Ile578fs | frameshift_variant | 9/13 | ENST00000255006.12 | NP_061866.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIN2 | ENST00000255006.12 | c.1731dupC | p.Ile578fs | frameshift_variant | 9/13 | 2 | NM_018993.4 | ENSP00000255006.7 | ||
RIN2 | ENST00000440354.2 | c.464-14250dupC | intron_variant | 1 | ENSP00000391239.2 | |||||
RIN2 | ENST00000484638.1 | n.1575dupC | non_coding_transcript_exon_variant | 5/9 | 1 | |||||
RIN2 | ENST00000648440.1 | c.1731dupC | p.Ile578fs | frameshift_variant | 8/12 | ENSP00000498085.1 |
Frequencies
GnomAD3 genomes AF: 0.00000666 AC: 1AN: 150090Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
150090
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1460098Hom.: 0 Cov.: 36 AF XY: 0.0000151 AC XY: 11AN XY: 726262
GnomAD4 exome
AF:
AC:
22
AN:
1460098
Hom.:
Cov.:
36
AF XY:
AC XY:
11
AN XY:
726262
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000666 AC: 1AN: 150090Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73144
GnomAD4 genome
AF:
AC:
1
AN:
150090
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
73144
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 20, 2021 | The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This sequence change creates a premature translational stop signal (p.Ile578Hisfs*7) in the RIN2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RIN2 are known to be pathogenic (PMID: 19631308). This premature translational stop signal has been observed in individuals with RIN2-related conditions (PMID: 24449201, 27277385). It has also been observed to segregate with disease in related individuals. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 137627). This variant is also known as c.1878_1879insC, c.1878dupC, p.Ile627Hisfs*7. - |
RIN2 syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2014 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at